Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

terminated120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Fatigue Management Programs for People With MS

NCT03550170
terminatednot_applicable

Evaluation of the International Diffusion of the European Code Against Cancer Through Mobile Telephony

NCT05992792
completednot_applicable

Helping Young Children Sleep

NCT01729715
completednot_applicable

Partner Notification Strategies for MSM in Peru

NCT01720641
completednot_applicable

Semi-automatic Response System(SARS)in Type 2 Diabetes

NCT01058733

Clinical Trials (5)

Showing 5 of 5 trials
NCT03550170Not Applicable

Fatigue Management Programs for People With MS

Completed
NCT05992792Not Applicable

Evaluation of the International Diffusion of the European Code Against Cancer Through Mobile Telephony

Terminated
NCT01729715Not Applicable

Helping Young Children Sleep

Completed
NCT01720641Not Applicable

Partner Notification Strategies for MSM in Peru

Completed
NCT01058733Not Applicable

Semi-automatic Response System(SARS)in Type 2 Diabetes

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5